Back to Search
Marlissa
by Glenmark Pharmaceuticals Inc., USAContraceptionCOCP
Actively PrescribedGeneric

Estrogen

Ethinyl Estradiol

0.03Mg

Progestin

Levonorgestrel

0.15Mg

Regimen Protocol

Monophasic 28 day

Androgenicity

High

Approval Date

2/29/2012

Additives
None
Inactive Ingredients
lactose monohydrateFD&C Yellow no. 6magnesium stearatemicrocrystalline cellulosepolacrilin potassiumpovidonetalcD&C Red no. 30

Contains common allergens

Active Alternative Brands
Alternative brands with the same formulation that are actively prescribed

Xiromed, LLC.

Altavera
Introvale

Aurobindo Pharma Limited

Ayuna
Iclevia

Afaxys Pharmaceuticals

Chateal

Lupin Pharmaceuticals, Inc.

Kurvelo

Amneal Pharmaceuticals Of New York Llc

Levonorgestrel And Ethinyl Estradiol

Glenmark Pharmaceuticals Ltd

Levonorgestrel And Ethinyl Estradiol

Lupin Ltd

Levonorgestrel And Ethinyl Estradiol

Xiromed Llc

Levonorgestrel And Ethinyl Estradiol
Levonorgestrel And Ethinyl Estradiol

Naari Pte Ltd

Levonorgestrel And Ethinyl Estradiol

Dr Reddys Laboratories Sa

Levora 0.15/30-28

Bayer plc

Microgynon 30

Pfizer Limited

Ovranette

Barr Laboratories Inc

Portia-28

Watson Laboratories Inc

Quasense

Teva Branded Pharmaceutical Products R And D Inc

Seasonale

Northstar Rx LLC

Setlakin

Have clinical questions about Marlissa?

Get evidence-based, cited answers from our AI co-pilot for hormone health.

Try Dama Assist

© 2026 Dama Health. All rights reserved.

This tool is intended for use by licensed healthcare professionals. It provides reference information on FDA-approved contraception and hormone therapy products. Results should not be used as a substitute for clinical judgment. Data is sourced from the FDA Orange Book and other FDA-sourced resources and may contain errors or omissions.

Last updated: July 2025 | Powered by Dama Health | Terms of Use | Privacy Policy